Vice President, Global Value, Access & Distribution

Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. As a leader in muscle biology and the mechanics of muscle performance, the company is developing small molecule drug candidates specifically engineered to impact muscle function and contractility.

Reporting to the Chief Commercial Officer (CCO), the Vice President and Head of Value, Access & Distribution is responsible for developing and leading market access strategy and execution to ensure optimal market access conditions throughout the life cycle of Cytokinetics’ products. This leader is responsible for providing global strategic leadership and direction for distribution, reimbursement, payer access, health economics and outcomes research pricing and contracting. They will build and lead a high performing Value and Access team to ensure appropriate access and solutions for patients and providers. As a member of the commercial leadership team, this leader will work across the organization to ensure a successful launch of our first product with subsequent indications and products to likely follow. They will partner with stakeholders across the company, including European value and access leadership, sales, marketing, medical affairs, finance, and supply chain to secure and maintain optimal market access for our products and support global commercial success.

Responsibilities

As a member of the Global Commercial Leadership Team, the VP, Global Value, Access & Distribution will:

• Lead the Global Value and Access functions at Cytokinetics to support reimbursement, maximize patient access, revenue, and profitability. Support the launch of our first and subsequent products to achieve our growth objectives.
• Lead Global Value and Access function including Health Economics and Outcomes Research (HEOR), Trade and Distribution, Field based payer account management teams, pricing and contracting. Initial focus is on launch of our first ever marketed product in the U.S. with additional products and indications expected to follow.
• Work collaboratively with EU Leadership Team to develop global pricing and reimbursement strategies and align them with EU stakeholders. Consult with EU Leaders to determine the EU launch sequence, considering international reference pricing. Support EU leaders in developing local value dossiers, economic value propositions, and innovative pricing solutions. Develop an understanding of the latest European market trends and the potential impact of market access policy of new drugs.
• Work with sales, marketing, and finance teams, recommend and execute a US managed care strategy for payer and key channels, including commercial insurers, Pharmacy Benefit Managers (PBMs), Integrated Health Networks (IHN), State Medicaid, Medicare, and Federal VA/DoD channels.
• Collaborate with marketing in the development of the product value proposition and other resources for payer account managers, US payers, as well as pull-through communications and resources for the US field team(s).
• Oversee our Trade and Distribution strategy. Collaborating with cross functional team members as well as managing day to day activities with wholesalers, distributors, and pharmacies. This includes and is not limited to setting up pharmacy networks including negotiating, managing, and implementing contracts and fees for service agreements as required. Working closely with the supply chain team and coordinating with our 3PL operations.
• Supervise global HEOR function while collaborating with Medical Affairs to inform data generation plans to strengthen the product value dossier including compelling and credible information for the US, and global payer customers. Oversee design and implementation of research studies and protocols leveraging real world data to highlight disease burden and to provide economic perspective to support product portfolio decisions, product reimbursement strategies and regulatory agency submissions. Collaborate with clinical research to add health economics measures, patient reported outcomes and endpoints to clinical trials and biostatisticians to analyze and report study results. Oversee development of budget impact and cost-effectiveness models.
• Serve as a key stakeholder on US pricing committee and make recommendations to ensure alignment with all key stakeholders as it relates to contracting, rebating, to price adjustments, best price, and other related elements. Furthermore, serve as key stakeholder on global pricing committee to establish floor pricing as well as provide consultation and alignment with European leaders on launch sequencing and pricing considering reference pricing.
• Wor